Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1805 of 5804
-
Your face may hold the key to your true age — AI decodes it
Knowledge-focused Recruiting nowWe aim to examine how FaceAge estimates (a measure of biological age based on facial features) change across different time points and identify factors that may influence these changes. This will help us understand the consistency and reliability of the FaceAge algorithm and allo…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New combo therapy aims to knock out bone metastasis pain
Symptom relief Recruiting nowThe objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).
Sponsor: Society of Interventional Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kids with rare lung condition: inhaled protein therapy in trial
Disease control Recruiting nowThe goal of this open-label study is to study molgramostim as a treatment for autoimmune pulmonary alveolar proteinosis (aPAP) in pediatric patients between age 6 and 18. The main questions it aims to answer are: The effect of molgramostim on breathing tests and activity in pedi…
Phase: PHASE3 • Sponsor: Savara Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study combines eastern and western medicine to restore periods in women
Disease control Recruiting nowThis study aims to validate the efficacy and safety of the "two-step cycle-regulating approach integrating Chinese and Western medicine: rapid restoration of menstruation with Western medicine, and nourish the kidney and soothe the liver, nourishing the essence, and reinforcing t…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy aims to boost immune response in hard-to-treat lung cancer
Disease control Recruiting nowA study of tolododekin alfa (also known as ANK-101) administered in combination with an anti-programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) antibody in participants with advanced or metastatic non-small cell lung cancer (NSCLC). Cohort A will enroll…
Phase: PHASE1 • Sponsor: Ankyra Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New ultrasound-guided technique may reduce stomach bleeding risk
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate whether Endoscopic Ultrasound-Guided Selective Variceal Devascularization (EUS-SVD) is effective in preventing the re-bleeding of gastric varices. It will also investigate the safety of EUS-SVD. The main questions it aims to answe…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New triple therapy could simplify h. pylori treatment
Disease control Recruiting now(1) To compare the efficacy and safety of a 14-day bismuth-amoxicillin-vonoprazan triple therapy versus a 14-day bismuth-based quadruple therapy as first-line treatments for H. pylori infection, and (2) To investigate the influence of H. pylori antibiotic resistance, along with h…
Phase: NA • Sponsor: Kaohsiung Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New pill aims to stop recurring chest infections in adults
Prevention Recruiting nowThe goal of this clinical trial is to assess if BUCCALIN® works In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIS). It will also evaluate the safety of BUCCALIN®. The primary aim is to reduce the number of infection episodes in the treatment period (12 m…
Phase: PHASE4 • Sponsor: Laboratorio Farmaceutico SIT srl • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Laser vs bipolar: which surgery best tames an oversized prostate?
Symptom relief Recruiting nowThis study compares the safety and efficacy of three endoscopic enucleation techniques for large prostates (\>100 mL) in patients with benign prostatic hyperplasia (BPH): Thulium Fiber Laser Enucleation (ThuFLEP), Holmium Laser Enucleation (HoLEP), and Bipolar Enucleation (B-TUEP…
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Holographic training may sharpen surgeon skills better than Old-School simulators
Knowledge-focused OngoingThis randomized controlled trial evaluates and compares the educational effectiveness of two arthroscopic training platforms: a traditional physical bench-model simulator and an immersive Mixed Reality (MR) simulator. Medical students and residents undergo a baseline assessment o…
Phase: NA • Sponsor: Universidade da Coruña • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Numbing shot during labor may prevent painful tears in First-Time moms
Symptom relief ENROLLING_BY_INVITATIONThe SOFT study investigates whether local anaesthesia during the second stage of labor decreases the incidence of perineal tears, including sphincter injuries, in women with their first vaginal birth (non-instrumental).
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a simple calcium shot cut C-Section bleeding?
Disease control Recruiting nowThis research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.
Phase: PHASE2 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New device offers hope for liver cancer patients out of options
Disease control Recruiting nowThe goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced hepatocellular carcinoma (HCC) who have no standard of care options can affect patients survival. The main questions it aims to answer are: * will the TheraBionic P1 device a…
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New insulin rival: can GZR4 beat current options for diabetes?
Disease control Recruiting nowThis study will be conducted to compare the efficacy, safety and patient-reported outcome of GZR4 and Insulin Icodec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could your own hair follicles cure baldness? new trial begins
Disease control Recruiting now(SINGLE SITE Study) The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365. Hair …
Phase: NA • Sponsor: Acorn Biolabs Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Youth-Led strategy aims to keep teens with HIV in care
Disease control Recruiting nowEnding the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-b…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New brain zapping combo aims to curb teen Self-Harm
Disease control Recruiting nowNSSI behavior is highly prevalent among adolescents, and its mechanisms are closely associated with attentional bias toward self-injury-related information and impulsivity, both of which may be related to reduced dlPFC activation levels. Introducing taVNS as a priming stimulus to…
Phase: NA • Sponsor: Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Hard-to-Treat colorectal cancer: targeted drug shows promise
Disease control Recruiting nowThe investigators hypothesize that patients with mCRC RAS-mutant eligible for a second line treatment with good prognostic features, identified as single metastatic site, long progression free survival (PFS) in first line treatment, might benefit from a personalized approach, wit…
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New stem cell collection strategy aims to reduce transplant complications
Disease control Recruiting nowThis prospective trial investigates the approach of G-CSF with risk-adapted Plerixafor use for stem cell mobilization in patients undergoing autologous stem cell transplantation. Since FDA approval in 2008, Plerixafor has been combined with G-CSF to mobilize stem cells, though th…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI could spot cancer in bones faster
Diagnosis Not yet recruitingProspective multicenter study to validate the diagnostic performance of whole body PET/CT foundation model for bone lesion detection
Sponsor: Shanghai 6th People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC